Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life
1
Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
2
Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 833, Taiwan
3
Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
4
School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan
*
Author to whom correspondence should be addressed.
Nutrients 2016, 8(12), 757; https://doi.org/10.3390/nu8120757
Received: 8 October 2016
/
Revised: 1 November 2016
/
Accepted: 21 November 2016
/
Published: 25 November 2016
(This article belongs to the Special Issue Dietary Fructose and Glucose: The Multifacetted Aspects of their Metabolism and Implication for Human Health)
Hypertension originates from early-life insults by so-called “developmental origins of health and disease” (DOHaD). Studies performed in the previous few decades indicate that fructose consumption is associated with an increase in hypertension rate. It is emerging field that tends to unfold the nutrient–gene interactions of maternal high-fructose (HF) intake on the offspring which links renal programming to programmed hypertension. Reprogramming interventions counteract disturbed nutrient–gene interactions induced by maternal HF intake and exert protective effects against developmentally programmed hypertension. Here, we review the key themes on the effect of maternal HF consumption on renal transcriptome changes and programmed hypertension. We have particularly focused on the following areas: metabolic effects of fructose on hypertension and kidney disease; effects of maternal HF consumption on hypertension development in adult offspring; effects of maternal HF consumption on renal transcriptome changes; and application of reprogramming interventions to prevent maternal HF consumption-induced programmed hypertension in animal models. Provision of personalized nutrition is still a faraway goal. Therefore, there is an urgent need to understand early-life nutrient–gene interactions and to develop effective reprogramming strategies for treating hypertension and other HF consumption-related diseases.
View Full-Text
Keywords:
developmental programming; developmental origins of health and disease (DOHaD); fructose; hypertension; kidney; next-generation sequencing; reprogramming; transcriptome
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Tain, Y.-L.; Chan, J.Y.H.; Hsu, C.-N. Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life. Nutrients 2016, 8, 757. https://doi.org/10.3390/nu8120757
AMA Style
Tain Y-L, Chan JYH, Hsu C-N. Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life. Nutrients. 2016; 8(12):757. https://doi.org/10.3390/nu8120757
Chicago/Turabian StyleTain, You-Lin, Julie Y.H. Chan, and Chien-Ning Hsu. 2016. "Maternal Fructose Intake Affects Transcriptome Changes and Programmed Hypertension in Offspring in Later Life" Nutrients 8, no. 12: 757. https://doi.org/10.3390/nu8120757
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
